Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Flunixin Meglumine Injection Market Growth 2021-2026

  • LP 4458073
  • 108 Pages
  • June 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of Flunixin Meglumine Injection will have significant change from previous year. By the most conservative estimates of global Flunixin Meglumine Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Flunixin Meglumine Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Flunixin Meglumine Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

10ml/Dose

20ml/ Dose

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Animal muscle pain

Animal febrile disease

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Norbrook

Zoteis

Merck Animal Health

Virbac Animal Health India Private Limited

MSD Animal Health

Bengal Remedies Limited

Wuhan Huisheng Biological Technology Co., Ltd.

Qilu Animal Health Products Co., Ltd.

Baimukang Animal Pharmaceutical Co., Ltd.

Shandong Zhongmu Veterinary Medicine Co., Ltd.

Hebei New Century Pharmaceutical Co., Ltd.

Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Flunixin Meglumine Injection Consumption 2016-2026

2.1.2 Flunixin Meglumine Injection Consumption CAGR by Region

2.2 Flunixin Meglumine Injection Segment by Type

2.2.1 10ml/Dose

2.2.2 20ml/ Dose

2.3 Flunixin Meglumine Injection Sales by Type

2.3.1 Global Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)

2.3.2 Global Flunixin Meglumine Injection Revenue and Market Share by Type (2016-2021)

2.3.3 Global Flunixin Meglumine Injection Sale Price by Type (2016-2021)

2.4 Flunixin Meglumine Injection Segment by Application

2.4.1 Animal muscle pain

2.4.2 Animal febrile disease

2.4.3 Others

2.5 Flunixin Meglumine Injection Sales by Application

2.5.1 Global Flunixin Meglumine Injection Sale Market Share by Application (2016-2021)

2.5.2 Global Flunixin Meglumine Injection Revenue and Market Share by Application (2016-2021)

2.5.3 Global Flunixin Meglumine Injection Sale Price by Application (2016-2021)

3 Global Flunixin Meglumine Injection by Company

3.1 Global Flunixin Meglumine Injection Sales Market Share by Company

3.1.1 Global Flunixin Meglumine Injection Sales by Company (2019-2021)

3.1.2 Global Flunixin Meglumine Injection Sales Market Share by Company (2019-2021)

3.2 Global Flunixin Meglumine Injection Revenue Market Share by Company

3.2.1 Global Flunixin Meglumine Injection Revenue by Company (2019-2021)

3.2.2 Global Flunixin Meglumine Injection Revenue Market Share by Company (2019-2021)

3.3 Global Flunixin Meglumine Injection Sale Price by Company

3.4 Global Manufacturers Flunixin Meglumine Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Flunixin Meglumine Injection Product Location Distribution

3.4.2 Players Flunixin Meglumine Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Flunixin Meglumine Injection by Region

4.1 Global Flunixin Meglumine Injection by Region

4.1.1 Global Flunixin Meglumine Injection Sales by Region

4.1.2 Global Flunixin Meglumine Injection Revenue by Region

4.2 Americas Flunixin Meglumine Injection Sales Growth

4.3 APAC Flunixin Meglumine Injection Sales Growth

4.4 Europe Flunixin Meglumine Injection Sales Growth

4.5 Middle East & Africa Flunixin Meglumine Injection Sales Growth

5 Americas

5.1 Americas Flunixin Meglumine Injection Sales by Country

5.1.1 Americas Flunixin Meglumine Injection Sales by Country (2016-2021)

5.1.2 Americas Flunixin Meglumine Injection Revenue by Country (2016-2021)

5.2 Americas Flunixin Meglumine Injection Sales by Type

5.3 Americas Flunixin Meglumine Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Flunixin Meglumine Injection Sales by Region

6.1.1 APAC Flunixin Meglumine Injection Sales by Region (2016-2021)

6.1.2 APAC Flunixin Meglumine Injection Revenue by Region (2016-2021)

6.2 APAC Flunixin Meglumine Injection Sales by Type

6.3 APAC Flunixin Meglumine Injection Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Flunixin Meglumine Injection by Country

7.1.1 Europe Flunixin Meglumine Injection Sales by Country (2016-2021)

7.1.2 Europe Flunixin Meglumine Injection Revenue by Country (2016-2021)

7.2 Europe Flunixin Meglumine Injection Sales by Type

7.3 Europe Flunixin Meglumine Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Flunixin Meglumine Injection by Country

8.1.1 Middle East & Africa Flunixin Meglumine Injection Sales by Country (2016-2021)

8.1.2 Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2016-2021)

8.2 Middle East & Africa Flunixin Meglumine Injection Sales by Type

8.3 Middle East & Africa Flunixin Meglumine Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Flunixin Meglumine Injection Distributors

10.3 Flunixin Meglumine Injection Customer

11 Global Flunixin Meglumine Injection Market Forecast

11.1 Global Flunixin Meglumine Injection Forecast by Region

11.1.1 Global Flunixin Meglumine Injection Forecast by Regions (2021-2026)

11.2.2 Global Flunixin Meglumine Injection Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Flunixin Meglumine Injection Forecast by Type

11.7 Global Flunixin Meglumine Injection Forecast by Application

12 Key Players Analysis

12.1 Norbrook

12.1.1 Norbrook Company Information

12.1.2 Norbrook Flunixin Meglumine Injection Product Offered

12.1.3 Norbrook Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Norbrook Main Business Overview

12.1.5 Norbrook Latest Developments

12.2 Zoteis

12.2.1 Zoteis Company Information

12.2.2 Zoteis Flunixin Meglumine Injection Product Offered

12.2.3 Zoteis Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Zoteis Main Business Overview

12.2.5 Zoteis Latest Developments

12.3 Merck Animal Health

12.3.1 Merck Animal Health Company Information

12.3.2 Merck Animal Health Flunixin Meglumine Injection Product Offered

12.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Merck Animal Health Main Business Overview

12.3.5 Merck Animal Health Latest Developments

12.4 Virbac Animal Health India Private Limited

12.4.1 Virbac Animal Health India Private Limited Company Information

12.4.2 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Offered

12.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Virbac Animal Health India Private Limited Main Business Overview

12.4.5 Virbac Animal Health India Private Limited Latest Developments

12.5 MSD Animal Health

12.5.1 MSD Animal Health Company Information

12.5.2 MSD Animal Health Flunixin Meglumine Injection Product Offered

12.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 MSD Animal Health Main Business Overview

12.5.5 MSD Animal Health Latest Developments

12.6 Bengal Remedies Limited

12.6.1 Bengal Remedies Limited Company Information

12.6.2 Bengal Remedies Limited Flunixin Meglumine Injection Product Offered

12.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Bengal Remedies Limited Main Business Overview

12.6.5 Bengal Remedies Limited Latest Developments

12.7 Wuhan Huisheng Biological Technology Co., Ltd.

12.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information

12.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Offered

12.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Main Business Overview

12.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Latest Developments

12.8 Qilu Animal Health Products Co., Ltd.

12.8.1 Qilu Animal Health Products Co., Ltd. Company Information

12.8.2 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Offered

12.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Qilu Animal Health Products Co., Ltd. Main Business Overview

12.8.5 Qilu Animal Health Products Co., Ltd. Latest Developments

12.9 Baimukang Animal Pharmaceutical Co., Ltd.

12.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information

12.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

12.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Main Business Overview

12.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Latest Developments

12.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.

12.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information

12.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Offered

12.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Main Business Overview

12.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Latest Developments

12.11 Hebei New Century Pharmaceutical Co., Ltd.

12.11.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information

12.11.2 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

12.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Hebei New Century Pharmaceutical Co., Ltd. Main Business Overview

12.11.5 Hebei New Century Pharmaceutical Co., Ltd. Latest Developments

12.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

12.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information

12.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

12.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Main Business Overview

12.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Latest Developments

12.13 Shandong Lukang Pharmaceutical Co., Ltd.

12.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information

12.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

12.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Main Business Overview

12.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Flunixin Meglumine Injection Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of 10ml/Dose

Table 3. Major Players of 20ml/ Dose

Table 4. Global Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)

Table 5. Global Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)

Table 6. Global Flunixin Meglumine Injection Revenue by Type (2016-2021) & ($ million)

Table 7. Global Flunixin Meglumine Injection Revenue Market Share by Type (2016-2021)

Table 8. Global Flunixin Meglumine Injection Sale Price by Type (2016-2021)

Table 9. Global Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)

Table 10. Global Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)

Table 11. Global Flunixin Meglumine Injection Value by Application (2016-2021)

Table 12. Global Flunixin Meglumine Injection Revenue Market Share by Application (2016-2021)

Table 13. Global Flunixin Meglumine Injection Sale Price by Application (2016-2021)

Table 14. Global Flunixin Meglumine Injection Sales by Company (2019-2021) & (K Doses)

Table 15. Global Flunixin Meglumine Injection Sales Market Share by Company (2019-2021)

Table 16. Global Flunixin Meglumine Injection Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Flunixin Meglumine Injection Revenue Market Share by Company (2019-2021)

Table 18. Global Flunixin Meglumine Injection Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Flunixin Meglumine Injection Producing Area Distribution and Sales Area

Table 20. Players Flunixin Meglumine Injection Products Offered

Table 21. Flunixin Meglumine Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Flunixin Meglumine Injection Sales by Region (2016-2021) (K Doses)

Table 25. Global Flunixin Meglumine Injection Sales Market Share by Region (2016-2021)

Table 26. Global Flunixin Meglumine Injection Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Flunixin Meglumine Injection Revenue Market Share by Region (2016-2021)

Table 28. Americas Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)

Table 29. Americas Flunixin Meglumine Injection Sales Market Share by Country (2016-2021)

Table 30. Americas Flunixin Meglumine Injection Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Flunixin Meglumine Injection Revenue Market Share by Country (2016-2021)

Table 32. Americas Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)

Table 33. Americas Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)

Table 34. Americas Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)

Table 35. Americas Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)

Table 36. APAC Flunixin Meglumine Injection Sales by Region (2016-2021) & (K Doses)

Table 37. APAC Flunixin Meglumine Injection Sales Market Share by Region (2016-2021)

Table 38. APAC Flunixin Meglumine Injection Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Flunixin Meglumine Injection Revenue Market Share by Region (2016-2021)

Table 40. APAC Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)

Table 41. APAC Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)

Table 42. APAC Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)

Table 43. APAC Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)

Table 44. Europe Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)

Table 45. Europe Flunixin Meglumine Injection Sales Market Share by Country (2016-2021)

Table 46. Europe Flunixin Meglumine Injection Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Flunixin Meglumine Injection Revenue Market Share by Country (2016-2021)

Table 48. Europe Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)

Table 49. Europe Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)

Table 50. Europe Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)

Table 51. Europe Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)

Table 53. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Flunixin Meglumine Injection Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)

Table 57. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)

Table 59. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Flunixin Meglumine Injection

Table 61. Key Application and Potential Industries of Flunixin Meglumine Injection

Table 62. Key Challenges of Flunixin Meglumine Injection

Table 63. Key Trends of Flunixin Meglumine Injection

Table 64. Flunixin Meglumine Injection Distributors List

Table 65. Flunixin Meglumine Injection Customer List

Table 66. Global Flunixin Meglumine Injection Sales Forecast by Region (2021-2026) & (K Doses)

Table 67. Global Flunixin Meglumine Injection Consumption Market Forecast by Region

Table 68. Global Flunixin Meglumine Injection Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Flunixin Meglumine Injection Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Flunixin Meglumine Injection Sales Forecast by Country (2021-2026) & (K Doses)

Table 71. Americas Flunixin Meglumine Injection Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Flunixin Meglumine Injection Sales Forecast by Region (2021-2026) & (K Doses)

Table 73. APAC Flunixin Meglumine Injection Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Flunixin Meglumine Injection Sales Forecast by Country (2021-2026) & (K Doses)

Table 75. Europe Flunixin Meglumine Injection Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Flunixin Meglumine Injection Sales Forecast by Country (2021-2026) & (K Doses)

Table 77. Middle East & Africa Flunixin Meglumine Injection Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Flunixin Meglumine Injection Sales Forecast by Type (2021-2026) & (K Doses)

Table 79. Global Flunixin Meglumine Injection Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Flunixin Meglumine Injection Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Flunixin Meglumine Injection Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Flunixin Meglumine Injection Sales Forecast by Application (2021-2026) & (K Doses)

Table 83. Global Flunixin Meglumine Injection Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Flunixin Meglumine Injection Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Flunixin Meglumine Injection Revenue Market Share Forecast by Application (2021-2026)

Table 86. Norbrook Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 87. Norbrook Flunixin Meglumine Injection Product Offered

Table 88. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 89. Norbrook Main Business

Table 90. Norbrook Latest Developments

Table 91. Zoteis Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 92. Zoteis Flunixin Meglumine Injection Product Offered

Table 93. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 94. Zoteis Main Business

Table 95. Zoteis Latest Developments

Table 96. Merck Animal Health Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 97. Merck Animal Health Flunixin Meglumine Injection Product Offered

Table 98. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 99. Merck Animal Health Main Business

Table 100. Merck Animal Health Latest Developments

Table 101. Virbac Animal Health India Private Limited Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 102. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Offered

Table 103. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 104. Virbac Animal Health India Private Limited Main Business

Table 105. Virbac Animal Health India Private Limited Latest Developments

Table 106. MSD Animal Health Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 107. MSD Animal Health Flunixin Meglumine Injection Product Offered

Table 108. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 109. MSD Animal Health Main Business

Table 110. MSD Animal Health Latest Developments

Table 111. Bengal Remedies Limited Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 112. Bengal Remedies Limited Flunixin Meglumine Injection Product Offered

Table 113. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 114. Bengal Remedies Limited Main Business

Table 115. Bengal Remedies Limited Latest Developments

Table 116. Wuhan Huisheng Biological Technology Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 117. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 118. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 119. Wuhan Huisheng Biological Technology Co., Ltd. Main Business

Table 120. Wuhan Huisheng Biological Technology Co., Ltd. Latest Developments

Table 121. Qilu Animal Health Products Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 122. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 123. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 124. Qilu Animal Health Products Co., Ltd. Main Business

Table 125. Qilu Animal Health Products Co., Ltd. Latest Developments

Table 126. Baimukang Animal Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 127. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 128. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 129. Baimukang Animal Pharmaceutical Co., Ltd. Main Business

Table 130. Baimukang Animal Pharmaceutical Co., Ltd. Latest Developments

Table 131. Shandong Zhongmu Veterinary Medicine Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 132. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 133. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 134. Shandong Zhongmu Veterinary Medicine Co., Ltd. Main Business

Table 135. Shandong Zhongmu Veterinary Medicine Co., Ltd. Latest Developments

Table 136. Hebei New Century Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 137. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 138. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 139. Hebei New Century Pharmaceutical Co., Ltd. Main Business

Table 140. Hebei New Century Pharmaceutical Co., Ltd. Latest Developments

Table 141. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 142. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 143. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 144. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Main Business

Table 145. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Latest Developments

Table 146. Shandong Lukang Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors

Table 147. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered

Table 148. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 149. Shandong Lukang Pharmaceutical Co., Ltd. Main Business

Table 150. Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Flunixin Meglumine Injection

Figure 2. Flunixin Meglumine Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Flunixin Meglumine Injection Sales Growth Rate 2016-2026 (K Doses)

Figure 7. Global Flunixin Meglumine Injection Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Flunixin Meglumine Injection Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of 10ml/Dose

Figure 10. Product Picture of 20ml/ Dose

Figure 11. Global Flunixin Meglumine Injection Sales Market Share by Type in 2020

Figure 12. Global Flunixin Meglumine Injection Revenue Market Share by Type (2016-2021)

Figure 13. Flunixin Meglumine Injection Consumed in Animal muscle pain

Figure 14. Global Flunixin Meglumine Injection Market: Animal muscle pain (2016-2021) & (K Doses)

Figure 15. Flunixin Meglumine Injection Consumed in Animal febrile disease

Figure 16. Global Flunixin Meglumine Injection Market: Animal febrile disease (2016-2021) & (K Doses)

Figure 17. Flunixin Meglumine Injection Consumed in Others

Figure 18. Global Flunixin Meglumine Injection Market: Others (2016-2021) & (K Doses)

Figure 19. Global Flunixin Meglumine Injection Sales Market Share by Application (2016-2021)

Figure 20. Global Flunixin Meglumine Injection Revenue Market Share by Application in 2020

Figure 21. Flunixin Meglumine Injection Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Flunixin Meglumine Injection Revenue Market Share by Company in 2020

Figure 23. Global Flunixin Meglumine Injection Sales Market Share by Regions (2016-2021)

Figure 24. Global Flunixin Meglumine Injection Revenue Market Share by Region in 2020

Figure 25. Americas Flunixin Meglumine Injection Sales 2016-2021 (K Doses)

Figure 26. Americas Flunixin Meglumine Injection Revenue 2016-2021 ($ Millions)

Figure 27. APAC Flunixin Meglumine Injection Sales 2016-2021 (K Doses)

Figure 28. APAC Flunixin Meglumine Injection Revenue 2016-2021 ($ Millions)

Figure 29. Europe Flunixin Meglumine Injection Sales 2016-2021 (K Doses)

Figure 30. Europe Flunixin Meglumine Injection Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Flunixin Meglumine Injection Sales 2016-2021 (K Doses)

Figure 32. Middle East & Africa Flunixin Meglumine Injection Revenue 2016-2021 ($ Millions)

Figure 33. Americas Flunixin Meglumine Injection Sales Market Share by Country in 2020

Figure 34. Americas Flunixin Meglumine Injection Revenue Market Share by Country in 2020

Figure 35. Americas Flunixin Meglumine Injection Sales Market Share by Type in 2020

Figure 36. Americas Flunixin Meglumine Injection Sales Market Share by Application in 2020

Figure 37. United States Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Flunixin Meglumine Injection Sales Market Share by Region in 2020

Figure 42. APAC Flunixin Meglumine Injection Revenue Market Share by Regions in 2020

Figure 43. APAC Flunixin Meglumine Injection Sales Market Share by Type in 2020

Figure 44. APAC Flunixin Meglumine Injection Sales Market Share by Application in 2020

Figure 45. China Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Flunixin Meglumine Injection Sales Market Share by Country in 2020

Figure 52. Europe Flunixin Meglumine Injection Revenue Market Share by Country in 2020

Figure 53. Europe Flunixin Meglumine Injection Sales Market Share by Type in 2020

Figure 54. Europe Flunixin Meglumine Injection Sales Market Share by Application in 2020

Figure 55. Germany Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Flunixin Meglumine Injection Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Application in 2020

Figure 64. Egypt Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Flunixin Meglumine Injection Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370